PG(O-18:0/18:3(6Z,9Z,12Z))

Metabolite details

Identifier

HWYZNMFCCJVYIK-HMKVOMNISA-N

InChI Key

HWYZNMFCCJVYIK-HMKVOMNISA-N

IUPAC name

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-octadecoxypropan-2-yl] (6Z,9Z,12Z)-octadeca-6,9,12-trienoate

Preferred name

PG(O-18:0/18:3(6Z,9Z,12Z))

INN name

—

Synonym

—

ChEBI

CHEBI:183181

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• WT_vs_WT_Aco
• G1_PBS_vs_G2_DSS
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d